PEAK6 Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,932
| Closed | -$1.85M | – | 3584 |
|
|
2024
Q2 | $1.85M | Buy |
8,932
+5,786
| +184% | +$1.31M | ﹤0.01% | 1422 |
|
|
2024
Q1 | $852K | Buy |
+3,146
| New | +$751K | ﹤0.01% | 2034 |
|
|
2023
Q3 | – | Sell |
-1,673
| Closed | -$343K | – | 4126 |
|
|
2023
Q2 | $352K | Buy |
1,673
+600
| +56% | +$119K | ﹤0.01% | 2472 |
|
|
2023
Q1 | $217K | Buy |
+1,073
| New | +$243K | ﹤0.01% | 3056 |
|
|
2022
Q4 | – | Sell |
-3,311
| Closed | -$723K | – | 4554 |
|
|
2022
Q3 | $652K | Sell |
3,311
-458
| -12% | -$98.9K | ﹤0.01% | 2614 |
|
|
2022
Q2 | $801K | Sell |
3,769
-639
| -14% | -$156K | ﹤0.01% | 3309 |
|
|
2022
Q1 | $1.25M | Sell |
4,408
-12,415
| -74% | -$3.83M | ﹤0.01% | 2289 |
|
|
2021
Q4 | $6.34M | Sell |
16,823
-24,850
| -60% | -$9.65M | 0.01% | 988 |
|
|
2021
Q3 | $17.2M | Buy |
41,673
+41,669
| +1,041,725% | +$17.3M | 0.04% | 445 |
|
|
2021
Q2 | $1K | Sell |
4
-12,794
| -100% | -$4.27M | ﹤0.01% | 4933 |
|
|
2021
Q1 | $3.71M | Buy |
12,798
+6,136
| +92% | +$1.71M | 0.01% | 1298 |
|
|
2020
Q4 | $1.67M | Buy |
+6,662
| New | +$1.59M | ﹤0.01% | 2007 |
|
|
2020
Q3 | – | Sell |
-1,043
| Closed | -$216K | – | 4450 |
|
|
2020
Q2 | $182K | Sell |
1,043
-13,372
| -93% | -$2.13M | ﹤0.01% | 3464 |
|
|
2020
Q1 | $1.82M | Buy |
14,415
+1,473
| +11% | +$221K | 0.01% | 1088 |
|
|
2019
Q4 | $1.98M | Buy |
12,942
+11,753
| +988% | +$1.63M | 0.01% | 1101 |
|
|
2019
Q3 | $157K | Sell |
1,189
-8,829
| -88% | -$1.18M | ﹤0.01% | 3031 |
|
|
2019
Q2 | $1.42M | Sell |
10,018
-1,606
| -14% | -$218K | 0.01% | 1541 |
|
|
2019
Q1 | $1.69M | Buy |
11,624
+10,319
| +791% | +$1.36M | 0.01% | 1428 |
|
|
2018
Q4 | $148K | Buy |
+1,305
| New | +$163K | ﹤0.01% | 3210 |
|
Other funds holding CRL
MG
EC